Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Alonso

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Oncology Reports|February 12, 2002
Cancer vaccines: an update with special focus on ganglioside antigensRoberto J Bitton, Marcel D Guthmann, Mariano R Gabri, et al.
International Journal of Oncology|September 4, 2012
Telomere structure and telomerase in health and disease (review)Daniel E Gomez, Romina G Armando, Hernán G Farina, et al.
Scientific Reports|September 8, 2022
Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapyLuisina M Solernó, Natasha T Sobol, María F Gottardo, et al.
Scientific Reports|September 8, 2020
Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonizationMaria F Gottardo, Carla S Capobianco, Johanna E Sidabra, et al.
Oncotargets and Therapy|November 8, 2014
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cellsGeorgina A Cardama, Nazareno Gonzalez, Matias Ciarlantini, et al.
Frontiers in Oncology|October 31, 2012
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataAna M Vázquez, Ana M Hernández, Amparo Macías, et al.
Clinical & Developmental Immunology|November 5, 2010
NGcGM3 ganglioside: a privileged target for cancer vaccinesLuis E Fernandez, Mariano R Gabri, Marcelo D Guthmann, et al.
Journal of Food Science|June 23, 2020
In vitro and in vivo antitumor activity of Yerba Mate extract in colon cancer modelsRocio S Garcia-Lazaro, Humberto Lamdan, Lorena G Caligiuri, et al.
Expert Opinion on Biological Therapy|January 22, 2010
Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapyMayrel Labrada, Marilyn Clavell, Yanín Bebelagua, et al.
International Journal of Molecular Medicine|April 22, 2008
Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patientsMariano R Gabri, Valeria Vazquez, Santiago Girón, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Oncology Reports|February 12, 2002
Cancer vaccines: an update with special focus on ganglioside antigensRoberto J Bitton, Marcel D Guthmann, Mariano R Gabri, et al.
International Journal of Oncology|September 4, 2012
Telomere structure and telomerase in health and disease (review)Daniel E Gomez, Romina G Armando, Hernán G Farina, et al.
Scientific Reports|September 8, 2022
Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapyLuisina M Solernó, Natasha T Sobol, María F Gottardo, et al.
Scientific Reports|September 8, 2020
Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonizationMaria F Gottardo, Carla S Capobianco, Johanna E Sidabra, et al.
Oncotargets and Therapy|November 8, 2014
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cellsGeorgina A Cardama, Nazareno Gonzalez, Matias Ciarlantini, et al.
Frontiers in Oncology|October 31, 2012
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataAna M Vázquez, Ana M Hernández, Amparo Macías, et al.
Clinical & Developmental Immunology|November 5, 2010
NGcGM3 ganglioside: a privileged target for cancer vaccinesLuis E Fernandez, Mariano R Gabri, Marcelo D Guthmann, et al.
Journal of Food Science|June 23, 2020
In vitro and in vivo antitumor activity of Yerba Mate extract in colon cancer modelsRocio S Garcia-Lazaro, Humberto Lamdan, Lorena G Caligiuri, et al.
Expert Opinion on Biological Therapy|January 22, 2010
Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapyMayrel Labrada, Marilyn Clavell, Yanín Bebelagua, et al.
International Journal of Molecular Medicine|April 22, 2008
Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patientsMariano R Gabri, Valeria Vazquez, Santiago Girón, et al.
Pageof 10